Sharemaestro Newsreel

ChemoMetec enters collaboration agreement with Roche Diagnostics

Chemometec A/S ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue a collaboration with the goal of creating synergies between the parties' solutions in the field of bioprocess monitoring, ChemoMetec and Roche Diagnostics have today …

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Veru Inc. -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients – -- Phase 2b PLATEAU clinical trial interim analysis and results on track for calendar Q1 2027-- -- In June …

Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

(Updates with day of announcement in first paragraph, Novo Nordisk's affiliation in the second paragraph, and latest stock moves in the fourth paragraph.)Scholar Rock Holding (SRRK) said Friday that the FDA review of its apitegromab Biologics License Application for spinal Silver Upgrade to read …

Conclusion of first tranche of share buyback programme

ISS A/S Company Announcement Copenhagen, 10 August 2026 No. 50/2026 Conclusion of first tranche of share buyback programme On 19 February 2026, ISS initiated a share buyback programme, see Company Announcement No. 10/2026. ISS has now concluded the first tranche of the share buyback …

Danske Bank share buy-back programme: transactions in week 32

Danske Bank A/S Company announcement no. 40 2026 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 33 44 00 00 10 August 2026 Page 1 of 2 Danske Bank share buy-back programme: transactions in week 32 On 5 February 2026, Danske Bank …

Storebrand Europe Index - announcement of prospectus

Storebrand Asset Management AS Lysaker, 10 August 2026 Storebrand hereby announces the Prospectus with Articles of Association Appendix to the Prospectus ("tillæg" relevant to Danish investors) for Storebrand Europe Index, an index aware equity fund. The fund has been accepted for listing at Nasdaq …

Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities

Novonesis (Novozymes A/S) Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities COPENHAGEN, Denmark, August 10 – Novonesis has signed an agreement with the intent to acquire MicroBioGen, an Australian biotechnology company with leading scientific expertise in yeast strains for industrial applications, …

New Beltone Illuminate Hearing Aids Automatically Adapt to Noise, Helping People Hear More Clearly in Everyday Life

Premium hearing aids' technological advancement prioritizes what users want to hear – clearly in noisy situations CHICAGO, Aug. 10, 2026 /PRNewswire/ -- . Following conversations in noisy restaurants, family gatherings, and other busy environments can be one of the biggest challenges for people with …

FLSmidth: Transactions under share buy-back programme

FLSmidth A/S COMPANY ANNOUNCEMENT NO. 38-2026 FLSmidth & Co. A/S 10 August 2026 Copenhagen, Denmark On 18 May 2026, FLSmidth & Co. A/S ("FLSmidth") initiated a share buy-back programme of up to DKK 1.0 billion (ref. Company Announcement no. 26-2025). Under the share buy-back …

Share Buy-back Programme – Transactions Week 32

Gabriel Holding A/S On 12 May 2026, Gabriel Holding A/S initiated a share buy-back programme. The buy-back runs from 12 May 2026 up to and including 16 March 2027. During this period, Gabriel Holding A/S may repurchase up to 94,500 shares corresponding to 5% …

OpenGate Capital to Acquire Maersk Training, the Global Safety Training and Gas-Safety Services Business of Maersk

NEW YORK & PARIS, August 10, 2026--(BUSINESS WIRE)--OpenGate Capital ("OpenGate"), a global private equity firm, announced today that it has signed a definitive agreement to acquire Maersk Training and its subsidiary Maersk H2S Safety Services. The company, a provider of global safety training and …

Nvidia, Eli Lilly, and Disney Show It’s Time to Back the Top Dogs

Investors are still skittish enough that they only want to buy proven winners, so backing the favorite is a smart strategy right now. Continue Reading

Ozempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Amazon.com Inc.'s Amazon Pharmacy will offer eligible Medicare beneficiaries weight-loss drugs for $50 per month through a new federal program aimed at expanding access. The company announced …

Jyske Bank (CPSE:JYSK) Following A Rally Still Looks Fully Valued On One Narrative

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Jyske Bank (CPSE:JYSK) stock has drawn attention after its recent price move, with the …

Jyske Bank (CPSE:JYSK) Stock May Be 42% Undervalued On Earnings Power

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Jyske Bank stock has delivered a strong 249.4% total return over the last 5 years, yet both the Excess Returns intrinsic value estimate and the market multiples …

Novo Nordisk (CPSE:NOVO B) Wins Dutch Injunction Over Compounded Semaglutide Spray

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Novo Nordisk (CPSE:NOVO B) secured a Dutch court injunction against Ceban Ziekenhuisfarmacie over an unapproved compounded semaglutide nasal spray. The ruling blocks production and distribution …

Novo Nordisk A/S Q2 Earnings Call Highlights

Key Points Interested in Novo Nordisk A/S? Here are five stocks we like better. Novo Nordisk raised its 2026 outlook after a better-than-expected start to the year, reporting Q2 adjusted sales of DKK 78.5 billion and 7% growth at constant exchange rates. However, lower …

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date

Today, August 7, 2026, Scholar Rock received customer notification from Catalent Indiana LLC (part of Novo Nordisk) that FDA classified the April 2026 site inspection of Catalent Indiana fill-finish facility as Official Action Indicated (OAI) Scholar Rock continuing to collaborate closely with FDA and …

Novo Nordisk Stock Rises After GLP-1 Antitrust Win

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish pharmaceutical giant behind Ozempic and Wegovy, edged nearly 2% higher during Friday's U.S. regular session after a federal judge threw out an antitrust lawsuit against Novo and Eli Lilly (NYSE:LLY). According to Reuters, …

Implementation of share buyback programme

Ringkjøbing Landbobank A/S Nasdaq Copenhagen Euronext Dublin London Stock Exchange Danish FSA Other stakeholders Date 7 August 2026 Implementation of share buyback programme In accordance with the corporate announcement of 3 July 2026, the bank will implement a new share buyback programme of DKK …

H+H International A/S (HH.CO) stock price, news, quote and history